Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are coming for popular weight-loss drugs.
Source link
#Novo #Nordisk #Eli #Lilly #shares #fall #Novos #pricecut #plan #Ozempic #Wegovy
Trending
- Here’s how to complete Worth Your Salt, the most annoying quest in Arc Raiders’ Shrouded Sky update
- Geron earnings up next: Can RYTELO sustain revenue momentum?
- Three myths about the Russia economic war
- Anthropic claims 3 Chinese companies ripped it off, using its AI tools to train their models: ‘How the turn tables’ | Fortune
- Anil Ambani Fraud Case: Anil Ambani fraud case: Not all old guidelines repealed by RBI’s 2024 master directions, says HC | Mumbai News – The Times of India
- A Minute with Alan® — Fine Dining – Alan Weiss, PhD
- Man arrested for using his minor children to commit theft near Jama Masjid market | Delhi News – The Times of India
- Tips and Tricks For Maximizing Your Online Casino Experience
Novo Nordisk and Eli Lilly shares both fall after Novo’s price-cut plan for Ozempic and Wegovy
By V. Alure
